Placental Growth Factor and Cardiac Inflammation

Accornero, 2011, Placental growth factor regulates cardiac adaptation and hypertrophy through a paracrine mechanism, Circ Res, 109, 272, 10.1161/CIRCRESAHA.111.240820 Autiero, 2003, Placental growth factor and its receptor, vascular endothelial growth factor receptor-1: Novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders, J Thromb Haemost, 1, 1356, 10.1046/j.1538-7836.2003.00263.x Black, 2004, TIMP3 checks inflammation, Nat Genet, 36, 934, 10.1038/ng0904-934 Carmeliet, 2001, Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions, Nat Med, 7, 575, 10.1038/87904 Carnevale, 2011, Placental growth factor regulates cardiac inflammation through the tissue inhibitor of metalloproteinases-3/tumor necrosis factor-α–converting enzyme axis: Crucial role for adaptive cardiac remodeling during cardiac pressure overload, Circulation, 124, 1337, 10.1161/CIRCULATIONAHA.111.050500 Clauss, 1996, The vascular endothelial growth factor receptor Flt-1 mediates biological activities: Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis, J Biol Chem, 271, 17629, 10.1074/jbc.271.30.17629 De Falco, 2002, Structure and function of placental growth factor, Trends Cardiovasc Med, 12, 241, 10.1016/S1050-1738(02)00168-8 DiSalvo, 1995, Purification and characterization of a naturally occurring vascular endothelial growth factor placenta growth factor heterodimer, J Biol Chem, 270, 7717, 10.1074/jbc.270.13.7717 Endo, 2007, Bone marrow derived cells are involved in the pathogenesis of cardiac hypertrophy in response to pressure overload, Circulation, 116, 1176, 10.1161/CIRCULATIONAHA.106.650903 Fischer, 2007, Survival pathways in hypertrophy and heart failure: The gp130-STAT axis, Basic Res Cardiol, 102, 393, 10.1007/s00395-007-0674-z Iyer, 2001, The crystal structure of human placenta growth factor-1 (PlGF-1), an angiogenic protein, at 2.0 A resolution, J Biol Chem, 276, 12153, 10.1074/jbc.M008055200 Izumiya, 2006, Vascular endothelial growth factor blockade promotes the transition from compensatory cardiac hypertrophy to failure in response to pressure overload, Hypertension, 47, 887, 10.1161/01.HYP.0000215207.54689.31 Knuefermann, 2004, The role of innate immune responses in the heart in health and disease, Trends Cardiovasc Med, 14, 1, 10.1016/j.tcm.2003.09.003 Koch, 2011, Signal transduction by vascular endothelial growth factor receptors, Biochem J, 437, 169, 10.1042/BJ20110301 Luttun, 2002, Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1, Nat Med, 8, 831, 10.1038/nm731 Maglione, 1991, Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor, Proc Natl Acad Sci U S A, 88, 9267, 10.1073/pnas.88.20.9267 Maglione, 1993, Two alternative mRNAs coding for the angiogenic factor, placenta growth factor (PlGF), are transcribed from a single gene of chromosome 14, Oncogene, 8, 925 Park, 1994, Placenta growth factor: Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR, J Biol Chem, 269, 25646, 10.1016/S0021-9258(18)47298-5 Patel, 2008, Placenta growth factor augments endothelin-1 and endothelin-B receptor expression via hypoxia-inducible factor-1 alpha, Blood, 112, 856, 10.1182/blood-2007-12-130567 Perelman, 2003, Placenta growth factor activates monocytes and correlates with sickle cell disease severity, Blood, 102, 1506, 10.1182/blood-2002-11-3422 Pipp, 2003, VEGFR-1–selective VEGF homologue PlGF is arteriogenic: Evidence for a monocyte-mediated mechanism, Circ Res, 92, 378, 10.1161/01.RES.0000057997.77714.72 Roncal, 2008, Beneficial effects of prolonged systemic administration of PlGF on late outcome of post-ischaemic myocardial performance, J Pathol, 216, 236, 10.1002/path.2408 Selvaraj, 2003, Mechanism of monocyte activation and expression of proinflammatory cytochemokines by placenta growth factor, Blood, 102, 1515, 10.1182/blood-2002-11-3423 Shiojima, 2005, Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure, J Clin Invest, 115, 2108, 10.1172/JCI24682 Walsh, 2007, Cardiac growth and angiogenesis coordinated by intertissue interactions, J Clin Invest, 117, 3176, 10.1172/JCI34126 Wang, 2009, Tumor necrosis factor-α–converting enzyme is a key regulator of agonist-induced cardiac hypertrophy and fibrosis, Hypertension, 54, 575, 10.1161/HYPERTENSIONAHA.108.127670 Wilson, 2004, Duality of innate stress responses in cardiac injury, repair, and remodeling, J Mol Cell Cardiol, 37, 801, 10.1016/j.yjmcc.2004.05.028 Zentilin, 2010, Cardiomyocyte VEGFR-1 activation by VEGF-B induces compensatory hypertrophy and preserves cardiac function after myocardial infarction, FASEB J, 24, 1467, 10.1096/fj.09-143180